Surgery Partners

SGRY · NASDAQ

$15.49+$0.78 (+5.30%)TodayMarket closed ·
Prev close $14.71

Latest news

  • Press releaseGlobe Newswire

    Surgery Partners Completes Sale of Ownership Interests in Idaho Falls Facilities to Intermountain Health; Updates Guidance to Include Impact of the Transaction

  • News

    Surgery Partners Q2 Adj. EPS $0.10 Beats $0.06 Estimate, Sales $848.900M Beat $830.366M Estimate

  • Press releaseGlobe Newswire

    Surgery Partners, Inc. Announces Second Quarter 2026 Results Reaffirms Full Year 2026 Guidance

  • NewsVandana Singh

    Surgery Partners Monetizes Idaho Assets As It Chases Faster Growth

  • Press releaseGlobe Newswire

    Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction

  • News

    Surgery Partners Q1 2026 Earnings Call Transcript

  • News

    Surgery Partners Q1 Adj. EPS $(0.03) Beats $(0.12) Estimate, Sales $810.900M Beat $797.892M Estimate

  • Press releaseGlobe Newswire

    Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance

  • News

    Earnings Scheduled For May 5, 2026

  • Press releaseGlobe Newswire

    Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details

  • Press releasePRNewswire

    SGRY: ADJUSTED EBITDA FELL SHY OF MANAGEMENT'S GUIDED PROJECTIONS -- LEVI & KORSINSKY, LLP INVESTIGATES

  • Press releasePRNewswire

    SGRY GUIDED FOR MARGIN EXPANSION WHILE HEADWINDS MOUNTED -- LEVI & KORSINSKY, LLP INVESTIGATES

  • Press releasePRNewswire

    SGRY: ADJUSTED EBITDA FELL SHY OF MANAGEMENT'S GUIDED PROJECTIONS -- LEVI & KORSINSKY, LLP INVESTIGATES

  • News

    Ortelius Urges Surgery Partners Overhaul After Underperformance, Calls For Hospital Divestitures, Board Refresh, And Management Change

  • Press releaseBusiness Wire

    Ortelius Delivers Open Letter to Surgery Partners Stockholders

  • News

    Analyst Expectations For Surgery Partners's Future

  • Press releasePRNewswire

    ZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERS

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releaseGlobe Newswire

    Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2025 Results; Sets 2026 Guidance; Announces Share Repurchase Program

  • News

    Earnings Preview: Surgery Partners

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRY

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRY

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • NewsAvi Kapoor

    Gold Jumps Over 2%; Dole Shares Gain After Q3 Results

  • Press releaseGlobe Newswire

    Surgery Partners, Inc. Announces Third Quarter 2025 Results

  • Press releaseGlobe Newswire

    Surgery Partners, Inc. Announces Second Quarter 2025 Results

  • News

    Earnings Scheduled For August 5, 2025

  • NewsVandana Singh

    Surgery Partners Rejects Bain Capital's Private Buyout Offer, Will Remain Independent

  • Press releaseGlobe Newswire

    SURGERY PARTNERS, INC. and Bain Capital Conclude Discussions

  • NewsVandana Singh

    Surgery Partners Misses Q1 Marks But Sticks To 2025 Outlook

  • NewsLekha Gupta

    Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?

  • NewsAvi Kapoor

    Royal Caribbean Cruises Posts Upbeat Earnings, Joins Brighthouse Financial, Invesco, Boeing And Other Big Stocks Moving Higher On Tuesday

  • NewsLekha Gupta

    Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio?

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.